FDA Febuxostat Review Could Boost Savient Gout Agent

FDA's convening of a November advisory committee on Takeda North America's febuxostat for treatment-failure gout may give a boost to Savient's Puricase, which could be used as an induction agent and may get its own panel review

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet